Join the 200th Anniversary Celebration

Issue IndexA searchable index of tables of contents

Find An Issue

By Volume and Issue
By Date

Table of contents for

September 6, 2007  Vol. 357 No. 10

Audio Summary of this Issue

Perspective
957-960
  • Free Full Text
  • Audio

Reauthorization of the State Children's Heath Insurance Program has become embroiled in a struggle over ideologies that divide the political parties, and President Bush has said he would veto the SCHIP bills approved by the House and Senate. John Iglehart ...

960-963

In a 2006 report, the Institute of Medicine implored the FDA to “embrace a culture of safety” by increasing the priority accorded to the safety of patients. Sheila Weiss Smith writes that the FDA's response to the IOM report demonstrates a lack of ...

Original Articles
965-976

In this randomized, placebo-controlled trial, the investigators administered epoetin alfa or placebo to 1460 medical, surgical, or trauma patients between 48 and 96 hours after admission to the intensive care unit. Treatment with epoetin alfa did not reduce the percentage of patients receiving a red-cell transfusion (the primary outcome) but did appear to reduce mortality in patients with trauma. However, this therapy was also associated with an increase in the incidence of thrombotic events.

977-986

Susceptibility to rheumatoid arthritis and systemic lupus erythematosus has been linked to a region on chromosome 2q. Fine-mapping of this locus, in patients with rheumatoid arthritis and in patients with lupus, traces the association to a single variant of the gene STAT4, which encodes a transcription factor activated by cytokines.

987-999

In two multicenter, randomized trials, the antiarrhythmic agent dronedarone was compared with placebo for the maintenance of sinus rhythm in patients with atrial fibrillation. With pooled data from the two trials, the median time to the recurrence of atrial fibrillation was 116 days in the dronedarone group and 53 days in the placebo group.

1000-1008

This report describes a special programming of pacemakers to reduce the risk of atrial fibrillation in patients with symptomatic bradycardia due to sinus-node disease. The pacing algorithm was designed to minimize the extent of ventricular paced beats in order to reduce ventricular desynchronization. The approach successfully reduced the risk of atrial fibrillation and provides a clinically useful alternative to standard pacing.

Clinical Practice
1009-1017
  • Full Text Audio

A healthy 45-year-old man is found on routine screening to have hypertriglyceridemia. He does not have diabetes, and he takes no medications. His father died at 55 years of age in an automobile accident, his mother is healthy at the age of 67 years, and he has two healthy older brothers. His body-mass index is 28. His fasting triglyceride level is 400 mg per deciliter, total cholesterol 230 mg per deciliter, LDL cholesterol 120 mg per deciliter, and HDL cholesterol 30 mg per deciliter. How should his case be assessed and managed?

Review Article
1018-1027

In addition to malaria, tuberculosis, and human immunodeficiency virus infection, several other infectious diseases are associated with substantial morbidity and mortality. In particular, 13 tropical diseases infect billions of people and cause disabilities such as blindness and heart failure, especially in persons who live in impoverished conditions. This review article describes approaches to the global control of these diseases.

Images in Clinical Medicine
1028
  • Free Full Text
  • Video

A healthy 60-year-old woman presented with hematemesis and melena, which she had had for 1 day. Her physical examination was unremarkable, as were the results of routine blood tests. On upper gastroduodenal endoscopy, a tapeworm was seen, along with ...

e11

This 26-year-old man with diabetes mellitus presented with poor glycemic control. He had no problems with his vision. Total serum cholesterol level was 1086 mg per deciliter with a triglyceride level of 11,929 mg per deciliter.

Clinical Problem-Solving
1029-1034

    A 64-year-old man with a history of coronary artery disease and peripheral vascular disease was admitted with a several-month history of fevers, chills, and fatigue. These symptoms began after he underwent percutaneous coronary intervention with placement of a stent in the left anterior descending coronary artery 10 months previously. A 5-day course of ciprofloxacin led to temporary relief of his symptoms, which returned 1 week after discontinuation of the antibiotic.

    Editorials
    1036-1037
    • Free Full Text
    • Audio

    In the grand tradition of bare-knuckle American politics, the reauthorization of the State Children's Health Insurance Program (SCHIP), which provides health coverage for low-income children, has become part of a war of political philosophies between a ...

    1037-1039

    The overall goals of clinical research in the intensive care unit (ICU) are to improve clinical outcomes through enhanced understanding of how critical illness develops and how such illness is best prevented, diagnosed, treated, or palliated. Several “...

    1039-1041

    Atrial fibrillation affects patients by increasing their risk of stroke and decreasing their quality of life. Unfortunately, even if restoration of sinus rhythm is possible, most patients remain at risk for stroke and need continued protection with ...

    Sounding Board
    1042-1047

      Academic medical centers are where most of the research sponsored by the National Institutes of Health (NIH) is performed. In the past decade, the centers have scaled up their research operations as the NIH budget doubled but now face shortfalls as fewer proposals are funded. In this Sounding Board article, an argument is made for more robust long-term NIH support.

      Correspondence
      1048-1050

      To the Editor: Kyle et al. (June 21 issue)1 propose a clinically useful risk-stratification model of progression from smoldering multiple myeloma to overt multiple myeloma. Gene-expression–signature data might enhance their model.

      Recent studies have ...

      1050-1051

      To the Editor: Hudes et al. (May 31 issue)1 suggest the use of temsirolimus as first-line treatment for metastatic renal-cell carcinoma. On the basis of their trial, temsirolimus was the second new drug to receive Food and Drug Administration (FDA) ...

      1051-1052

      To the Editor: One of the shortcomings of the article on local therapy and survival in breast cancer, by Punglia et al. (June 7 issue),1 is the claim that a decrease in breast-cancer mortality and overall mortality as a result of radiation therapy “...

      1052-1053

      To the Editor: In the review of early breast-cancer management by Hayes (June 14 issue),1 the effects of selective estrogen-receptor modulators on the uterus (shown in Table 5 of the article) might have been clearer if raloxifene, which does not ...

      1054-1056

      To the Editor: Gastrointestinal stromal tumors may be sporadic or inherited in an autosomal dominant manner, alone or as a component of a syndrome associated with other tumors, such as in the context of neurofibromatosis type 1.1 We have described seven ...

      1056-1057

      The findings of a randomized study of three antiretroviral regimens for the initial treatment of HIV infection show that the triple-nucleoside regimen was inferior virologically to both the four-drug regimen and the three-drug, standard-of-care regimen.

      Book Reviews
      1058-1059

      Oncology is a relatively young field. Although surgical and radiation treatments for cancer have long histories, the development of effective anticancer drugs began just 50 years ago. David Nathan is among the physicians who have witnessed the entire ...

      1059-1060

      The pioneering, Nobel Prize–winning work of E. Donnall Thomas in the 1960s and 1970s demonstrated that certain patients with leukemia could be cured with a combination of radiation and high-dose chemotherapy. These patients could survive such treatments ...

      1060-1061

      The movement to reduce disparities in biomedical research has been driven largely by policies and practices that are designed to include underrepresented groups. Using a historical approach, Epstein provides a thorough account of how this movement created ...

      1061-1062

      In the past few years, a handful of books have aimed to help members of institutional review boards (IRBs) fulfill their role of protecting those who participate in approved biomedical and behavioral studies. This book, the latest addition to the list, ...